TickerFacts.

Company research / NDRA

ENDRA Life Sciences Inc. (NDRA)

Build a valuation ↗↓ Download CSV

CIK 0001681682 · Nasdaq · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2020-12-31, ENDRA Life Sciences Inc. reported revenue of $0.

Key ratios (year ended 2020-12-31)

-163.6%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 8-K · 2026-08-17

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue—————$0$0$6.2K$351.6K—
Cost of Revenue—————$0$0$0$172.8K—
Gross Profit—————$0$0$6.2K$178.8K$279.7K
Operating Income-$5.76M-$10.82M-$10.52M-$13.16M-$11.50M-$11.50M-$10.84M-$9.02M-$4.63M-$1.79M
Net Income-$7.03M-$11.51M-$10.06M-$13.18M-$11.23M-$11.73M-$13.31M-$9.80M-$5.38M-$2.78M
EPS (Diluted)$-8.93$-56.94$-2766.85———————
Total Assets$3.85M$4.45M$6.75M$9.27M$12.87M$8.76M$7.18M$7.22M$6.12M$490.8K
Total Liabilities$1.59M$1.89M$1.10M$2.07M$2.09M$1.60M$2.42M$974.6K$848.2K$1.38M
Shareholders' Equity$2.26M$2.56M$5.66M$7.20M$10.78M$7.17M$4.76M$6.25M$5.28M-$893.8K
Operating Cash Flow-$5.18M-$7.40M-$9.55M-$12.77M-$11.12M-$10.75M-$8.59M-$7.70M-$3.30M-$1.32M
Capital Expenditures$17.3K$16.0K$33.9K$202.6K$45.0K$75.3K$43.6K$100.0K$7.9K—
Shares Outstanding1.18M536.9K5.9K3.17M2.13M34.05M8.42M7.42M3.92M723.3K
Weighted Average Diluted Shares787.0K202.1K3.6K———————
EPS (Basic)$-8.93$-56.94—$-4.56$-5.55$-0.63————